Fc Receptor-Like 1 as a Promising Target for Immunotherapeutic Interventions of B-Cell-Related Disorders.

Conclusions: These results suggest that FCRL1 can play a key role in the activation of human B-cell responses and has the potential to serve as a target for immunotherapy of FCRL1 positive B-cell-related disorders. PMID: 31798301 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31798301?dopt=Abstract

Source: Biomarker Insights - December 6, 2019 Category: General Medicine Authors: Yousefi Z, Sharifzadeh S, Yar-Ahmadi V, Andalib A, Eskandari N Tags: Biomark Insights Source Type: research